Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,243 | 58 | 98.9% |
| Education | $14.00 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $348.13 | 16 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $130.22 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $85.61 | 4 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $69.65 | 3 | $0 (2023) |
| Dermavant Sciences, Inc. | $66.64 | 4 | $0 (2024) |
| Stemline Therapeutics Inc. | $65.11 | 1 | $0 (2019) |
| MAYNE PHARMA INC. | $58.37 | 3 | $0 (2022) |
| Incyte Corporation | $54.98 | 2 | $0 (2022) |
| LEO Pharma Inc. | $47.04 | 3 | $0 (2019) |
| PFIZER INC. | $43.98 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $122.08 | 6 | ABBVIE INC. ($55.85) |
| 2023 | $273.36 | 13 | ABBVIE INC. ($139.17) |
| 2022 | $377.81 | 19 | ABBVIE INC. ($115.31) |
| 2021 | $73.70 | 4 | Novartis Pharmaceuticals Corporation ($23.09) |
| 2020 | $80.14 | 4 | MAYNE PHARMA INC. ($23.88) |
| 2019 | $130.37 | 5 | Stemline Therapeutics Inc. ($65.11) |
| 2018 | $171.86 | 6 | E.R. Squibb & Sons, L.L.C. ($97.46) |
| 2017 | $28.02 | 2 | Lilly USA, LLC ($15.38) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/07/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: Dermatology | ||||||
| 05/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: IMMUNOLOGY | ||||||
| 04/25/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: DERMATOLOGY | ||||||
| 04/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: IMMUNOLOGY | ||||||
| 04/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: DERMATOLOGY | ||||||
| 04/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2023 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $7.58 | General |
| Category: DERMATOLOGY | ||||||
| 06/19/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Immunology | ||||||
| 05/31/2023 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug), ARAZLO | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Podiatry | ||||||
| 05/19/2023 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 GraftGuide, Kerecis Omega3 SurgiClose | Food and Beverage | Cash or cash equivalent | $29.27 | General |
| Category: Wound Care | ||||||
| 04/25/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: IMMUNOLOGY | ||||||
| 04/17/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: IMMUNOLOGY | ||||||
| 04/04/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Immunology | ||||||
| 03/28/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/20/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: IMMUNOLOGY | ||||||
| 02/27/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: IMMUNOLOGY | ||||||
| 02/13/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: ONCOLOGY | ||||||
| 02/01/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: FACIAL AESTHETICS | ||||||
| 01/30/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: IMMUNOLOGY | ||||||
| 11/29/2022 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: DERMATOLOGY | ||||||
| 11/28/2022 | Dermavant Sciences, Inc. | VTAMA (Drug) | Education | In-kind items and services | $14.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2022 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.27 | General |
| Category: Immunology | ||||||
| 10/31/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO | Food and Beverage | In-kind items and services | $16.10 | General |
| 10/24/2022 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.49 | General |
| Category: Immunology | ||||||
| 10/17/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 8,905 | 22,466 | $2.6M | $694,743 |
| 2022 | 17 | 7,407 | 18,737 | $2.1M | $519,445 |
| 2021 | 17 | 7,290 | 21,591 | $2.4M | $604,761 |
| 2020 | 18 | 7,511 | 21,399 | $2.3M | $595,223 |
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 6,954 | 18,394 | $2.1M | $549,416 | 26.2% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 611 | 1,121 | $152,871 | $47,836 | 31.3% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 278 | 800 | $109,379 | $29,668 | 27.1% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 242 | 497 | $65,517 | $23,398 | 35.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 124 | 156 | $23,060 | $7,790 | 33.8% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 246 | 436 | $49,841 | $7,760 | 15.6% |
| 88344 | Special stained specimen slides to examine tissue, each multiplex procedure | Office | 2023 | 50 | 92 | $12,458 | $5,800 | 46.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 74 | 85 | $17,807 | $5,499 | 30.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 59 | 67 | $12,557 | $3,689 | 29.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 86 | 116 | $14,428 | $3,214 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 41 | $9,805 | $2,972 | 30.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 18 | 21 | $6,551 | $2,300 | 35.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 72 | 545 | $5,897 | $2,235 | 37.9% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 28 | 61 | $4,945 | $1,973 | 39.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 24 | 34 | $3,167 | $1,194 | 37.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 5,571 | 14,806 | $1.6M | $392,446 | 24.8% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2022 | 501 | 971 | $131,502 | $34,871 | 26.5% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2022 | 221 | 739 | $100,815 | $23,466 | 23.3% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2022 | 230 | 504 | $61,821 | $18,787 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 125 | 162 | $26,064 | $8,713 | 33.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 91 | 105 | $22,159 | $7,435 | 33.6% |
| 88344 | Special stained specimen slides to examine tissue, each multiplex procedure | Office | 2022 | 54 | 118 | $15,727 | $6,147 | 39.1% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2022 | 223 | 412 | $50,117 | $5,680 | 11.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 61 | 78 | $16,869 | $3,946 | 23.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 37 | 41 | $10,001 | $3,348 | 33.5% |
About Dr. Sara Kantrow, MD
Dr. Sara Kantrow, MD is a Dermatopathology healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1851507073.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sara Kantrow, MD has received a total of $1,257 in payments from pharmaceutical and medical device companies, with $122.08 received in 2024. These payments were reported across 59 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,243).
As a Medicare-enrolled provider, Kantrow has provided services to 31,113 Medicare beneficiaries, totaling 84,193 services with total Medicare billing of $2.4M. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Practice Information
- Specialty Dermatopathology
- Other Specialties Dermatology
- Location Nashville, TN
- Active Since 05/15/2007
- Last Updated 03/07/2023
- Taxonomy Code 207ND0900X
- Entity Type Individual
- NPI Number 1851507073
Products in Payments
- SKYRIZI (Biological) $227.17
- OPDIVO (Biological) $97.46
- VTAMA (Drug) $66.64
- ELZONRIS (Drug) $65.11
- RINVOQ (Biological) $58.40
- COSENTYX (Biological) $58.19
- OPZELURA (Drug) $54.98
- DUPIXENT (Biological) $52.05
- LIBTAYO (Biological) $49.53
- ENSTILAR (Drug) $47.04
- EUCRISA (Drug) $43.98
- DORYX (Drug) $37.02
- TREMFYA (Drug) $33.95
- HUMIRA (Biological) $33.52
- TALTZ (Drug) $33.02
- Sotyktu (Drug) $32.76
- Kerecis Omega3 SurgiClose (Device) $29.27
- BOTOX (Biological) $29.04
- COSENTYX (Drug) $27.42
- BLU-U (Medical Supply) $21.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatopathology Doctors in Nashville
Dr. Jeffrey Zwerner, Md, Phd, MD, PHD
Dermatopathology — Payments: $23,486
Alan Boyd, M.d, M.D
Dermatopathology — Payments: $288.98
Jason Robbins, M.d, M.D
Dermatopathology — Payments: $233.84
Dr. Harrison Warner, Md, MD
Dermatopathology — Payments: $141.71
Dr. Amy Parsons, Md, MD
Dermatopathology — Payments: $89.84
Dr. Jonathan Cuda, M.d, M.D
Dermatopathology — Payments: $26.90